The University of Southampton
University of Southampton Institutional Repository

Regulation of collagen dissolution in the human uterine cervix

Regulation of collagen dissolution in the human uterine cervix
Regulation of collagen dissolution in the human uterine cervix

Collagen dissolution in the non-pregnant human uterine cervix was investigated by following the spontaneous release of hydroxyproline containing peptides from tissue explants into the surrounding culture medium. Typically, the release of these peptides was low during early days of culture and then increased until at least day 18. Progesterone and oestradiol-17 A significantly inhibited collagen dissolution. The latter was only effective if the tissue was maintained in a low oestrogen containing environment, suggesting the oestrogen receptor may be 'labile'. It is therefore concluded that the integrity of the connective tissue framework of the human cervix could be in part under steroid hormone control. Prostaglandins are used clinically to soften the human cervix, but neither PGE2 or Pr~F2 had a significant effect on collagen breakdown. Arachidonic acid, however, was a potent stimulant of collagen dissolution, the action of which was not blocked by indomethacin at concentrations that inhibit prostaglandin synthesis; possible mechanisms of action of arachidonic acid are discussed. Drugs which inhibit prostaglandin synthetase such as indomethacin and meclofenamic acid inhibit collagen dissolution, but only with concentrations greater than that required to inhibit prostaglandin synthesis. In culture cervix explants synthesise PGE, PGF and 6 keto PGFla. The synthesis of these prostanoids could not be positively correlated with the profile for collagen breakdown. It is therefore concluded that it appears unlikely that prostaglandins soften the cervix in vivo by a direct stimulation of collagen breakdown, but changes in the collagen framework mediated by other mechanisms cannot be excluded. In the rat, the softness of the cervix was positively correlated with the degree of acid solubility of collagen. Arachidonic acid, administered on day 18 of pregnancy, softened the cervix, increased the collagen solubility and decreased the collagen concentration. It is therefore possible that this drug softens the cervix in vivo by enhanced enzymatic collagen degradation, this may be mediated by collagenase or other proteases. From this and other studies collagenolytic enzymes appear to have a role in cervix softening, although the interrelationship between these enzymes and other biochemical changes, such as altered glycosaminoglycans, requires determination.

University of Southampton
Wallis, Robert M
Wallis, Robert M

Wallis, Robert M (1980) Regulation of collagen dissolution in the human uterine cervix. University of Southampton, Doctoral Thesis.

Record type: Thesis (Doctoral)

Abstract

Collagen dissolution in the non-pregnant human uterine cervix was investigated by following the spontaneous release of hydroxyproline containing peptides from tissue explants into the surrounding culture medium. Typically, the release of these peptides was low during early days of culture and then increased until at least day 18. Progesterone and oestradiol-17 A significantly inhibited collagen dissolution. The latter was only effective if the tissue was maintained in a low oestrogen containing environment, suggesting the oestrogen receptor may be 'labile'. It is therefore concluded that the integrity of the connective tissue framework of the human cervix could be in part under steroid hormone control. Prostaglandins are used clinically to soften the human cervix, but neither PGE2 or Pr~F2 had a significant effect on collagen breakdown. Arachidonic acid, however, was a potent stimulant of collagen dissolution, the action of which was not blocked by indomethacin at concentrations that inhibit prostaglandin synthesis; possible mechanisms of action of arachidonic acid are discussed. Drugs which inhibit prostaglandin synthetase such as indomethacin and meclofenamic acid inhibit collagen dissolution, but only with concentrations greater than that required to inhibit prostaglandin synthesis. In culture cervix explants synthesise PGE, PGF and 6 keto PGFla. The synthesis of these prostanoids could not be positively correlated with the profile for collagen breakdown. It is therefore concluded that it appears unlikely that prostaglandins soften the cervix in vivo by a direct stimulation of collagen breakdown, but changes in the collagen framework mediated by other mechanisms cannot be excluded. In the rat, the softness of the cervix was positively correlated with the degree of acid solubility of collagen. Arachidonic acid, administered on day 18 of pregnancy, softened the cervix, increased the collagen solubility and decreased the collagen concentration. It is therefore possible that this drug softens the cervix in vivo by enhanced enzymatic collagen degradation, this may be mediated by collagenase or other proteases. From this and other studies collagenolytic enzymes appear to have a role in cervix softening, although the interrelationship between these enzymes and other biochemical changes, such as altered glycosaminoglycans, requires determination.

This record has no associated files available for download.

More information

Published date: 1980

Identifiers

Local EPrints ID: 459273
URI: http://eprints.soton.ac.uk/id/eprint/459273
PURE UUID: bb53993d-6631-43ec-9b85-79e9c4ce8049

Catalogue record

Date deposited: 04 Jul 2022 17:07
Last modified: 04 Jul 2022 17:07

Export record

Contributors

Author: Robert M Wallis

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×